Subsidiaries Silence EContact Us>
Silence Therapeutics Silence Therapeutics
▲
169.00p (+1.00p)
Vol: 5635
(15-minute delayed)
View full stock quote


  • Home
  • About Us
  • Platform Technologies
  • Pipeline
  • Collaborations
  • Investor Relations
  • News & Events
  • RNAi Hub
  • Menu
  • About Us
    • Overview
    • Strategy
    • History
    • Management
    • Board Of Directors
    • Scientific Advisory Board
    • Careers
  • RNAI Platform
    • Overview
    • Delivery Platform
    • RNAi Platform
    • RNA Interference
    • Intellectual Property
    • Publications
    • Glossary
  • Pipeline
    • Overview
    • Pre-Clinical development
  • Collaborations
    • Overview
    • Silence's Strengths
    • Partnerships
    • Partnering Opportunities
  • Investor Relations
    • Overview
    • Press Releases
    • Reports and Disclosures
    • Analyst Coverage
  • News & Events
    • Press Releases
    • Events
    • In the News
    • Publications
  • RNAi Hub
  • Contact
 
 
News Events
Publications Companies
Clinical Trials  

Tag Archives: Mirapharm

Post navigation

← Older posts
  • Tekmira Announces Election of Directors

    0 Replies

    May 17, 2013

    Tekmira Announces Election of Directors Contine Reading & Discuss→

    Posted in :  Companies |  News |  Other News |  Syndicated |  Tagged in :  Mirapharm | 
  • Tekmira Presents LNP Technology Innovations at Scientific Symposium

    0 Replies

    May 15, 2013

    Tekmira Presents LNP Technology Innovations at Scientific Symposium Contine Reading & Discuss→

    Posted in :  Companies |  News |  Other News |  Syndicated |  Tagged in :  Mirapharm | 
  • Tekmira Provides Corporate Update and Announces First Quarter 2013 Results

    0 Replies

    May 14, 2013

    Tekmira Provides Corporate Update and Announces First Quarter 2013 Results Contine Reading & Discuss→

    Posted in :  Companies |  News |  Other News |  Syndicated |  Tagged in :  Mirapharm | 
  • Tekmira Conference Call and Webcast Advisory: Corporate Update and First Quarter Financial Results

    0 Replies

    May 09, 2013

    Tekmira Conference Call and Webcast Advisory: Corporate Update and First Quarter Financial Results Contine Reading & Discuss→

    Posted in :  Companies |  News |  Other News |  Syndicated |  Tagged in :  Mirapharm | 
  • Tekmira Provides Update on U.S. Government Sponsored TKM-Ebola Program

    0 Replies

    May 08, 2013

    Tekmira Provides Update on U.S. Government Sponsored TKM-Ebola Program Contine Reading & Discuss→

    Posted in :  Companies |  News |  Other News |  Syndicated |  Tagged in :  Mirapharm | 
  • Tekmira’s Collaborators at the National Cancer Institute Present Preclinical Data at the Annual Meeting of the American Association for Cancer Research (AACR)

    0 Replies

    April 10, 2013

    Tekmira's Collaborators at the National Cancer Institute Present Preclinical Data at the Annual Meeting of the American Association for Cancer Research (AACR) Contine Reading & Discuss→

    Posted in :  Companies |  News |  Other News |  Syndicated |  Tagged in :  Mirapharm | 
  • Tekmira Presents Data From Its TKM-PLK1 Phase I Clinical Trial at American Association for Cancer Research (AACR) Meeting

    0 Replies

    April 09, 2013

    Tekmira Presents Data From Its TKM-PLK1 Phase I Clinical Trial at American Association for Cancer Research (AACR) Meeting Contine Reading & Discuss→

    Posted in :  Companies |  News |  Other News |  Syndicated |  Tagged in :  Mirapharm | 
  • Tekmira Provides Corporate Update and Announces Year-End Audited 2012 Results

    0 Replies

    March 27, 2013

    Tekmira Provides Corporate Update and Announces Year-End Audited 2012 Results Contine Reading & Discuss→

    Posted in :  Companies |  News |  Other News |  Syndicated |  Tagged in :  Mirapharm | 
  • Tekmira Conference Call and Webcast Advisory: Corporate Update and Year-End 2012 Financial Results

    0 Replies

    March 20, 2013

    Tekmira Conference Call and Webcast Advisory: Corporate Update and Year-End 2012 Financial Results Contine Reading & Discuss→

    Posted in :  Companies |  News |  Other News |  Syndicated |  Tagged in :  Mirapharm | 
  • Tekmira Outlines Key 2013 Product Development and Corporate Milestones

    0 Replies

    February 12, 2013

    Tekmira Outlines Key 2013 Product Development and Corporate Milestones Contine Reading & Discuss→

    Posted in :  Companies |  News |  Other News |  Syndicated |  Tagged in :  Mirapharm | 

Post navigation

← Older posts

Sign up to receive alerts

>

Submit

ARCHIVES

Open

2013

  • June 2013
  • May 2013
  • April 2013
  • March 2013
  • February 2013
  • January 2013
Open

2012

  • December 2012
  • November 2012
  • October 2012
  • September 2012
  • August 2012
  • July 2012
  • June 2012
  • May 2012
  • April 2012
  • March 2012
  • February 2012
  • January 2012
Open

2011

  • December 2011
  • November 2011
  • October 2011
  • September 2011
  • August 2011
  • July 2011
  • June 2011
  • May 2011
  • April 2011
  • March 2011
  • February 2011
  • January 2011
Open

2010

  • December 2010
  • November 2010
  • October 2010
  • September 2010
  • August 2010
  • July 2010
  • June 2010
  • May 2010
  • April 2010
  • March 2010
  • February 2010
  • January 2010
Open

2009

  • December 2009
  • November 2009
  • October 2009
  • September 2009
  • August 2009
  • July 2009
  • June 2009
  • May 2009
  • April 2009
  • March 2009
  • February 2009
  • January 2009
Open

2008

  • December 2008
  • November 2008
  • October 2008
  • September 2008
  • August 2008
  • July 2008
  • June 2008
  • May 2008
  • April 2008
  • March 2008
  • February 2008
  • January 2008
Open

2007

  • December 2007
  • November 2007
  • October 2007
  • September 2007
  • August 2007
  • July 2007
  • June 2007
  • May 2007
  • April 2007
  • March 2007
  • February 2007
  • January 2007
Open

2006

  • November 2006
  • October 2006
  • September 2006
  • August 2006
  • July 2006
  • June 2006
  • May 2006
  • April 2006
  • March 2006
Open

2005

  • December 2005
  • November 2005
  • August 2005
  • July 2005
  • June 2005
  • May 2005
  • April 2005
  • March 2005
  • February 2005
  • January 2005
Open

2004

  • October 2004
  • July 2004
  • June 2004
Open

2003

  • December 2003
  • May 2003

TAGS

Arrowhead Research Corporation Biochem Biophys Res Commun Biochim Biophys Acta Biomaterials Blood BMC Genomics BMC Plant Biol cancer Cancer Res Cell Curr Biol Dev Biol Genes Dev Genetics Industry News Insect Biochem Mol Biol Int J Oncol J Biol Chem J Cell Sci J Virol Mariana Bio Methods Mol Biol microRNA Micro RNA Blog Mirapharm mirna Mol Biol Cell Mol Biol Rep Mol Cell Biol Mol Ther Mol Ther Nucleic Acids Nucleic Acids Res Oncol Rep Plant Biotechnol J Plant Physiol PLoS Genet PLoS One PLoS Pathog Proc Natl Acad Sci U S A Report Report Linker RNAi Santaris silence therapeutics Uncategorized

Quick Links

  • Home
  • About Us
  • Platform Technologies
  • Pipeline
  • Collaborations
  • Investor Relations
  • News & Events
  • RNAi HUB
  • Site Map

Contact

3 Shortlands
Hammersmith
London W6 8DA
United Kingdom


Tel:+44 (0) 333 9880 140
Fax:+44 (0) 795 731 8494
Silence Therapeutics

Copyright © 2013 Silence Therapeutics.
All rights reserved.

Terms of Use
Forward-Looking Statement